{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:27:13Z","timestamp":1749061633487},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T00:00:00Z","timestamp":1370563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00467-013-2499-3","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T08:19:27Z","timestamp":1370506767000},"page":"2053-2056","source":"Crossref","is-referenced-by-count":9,"title":["Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy"],"prefix":"10.1007","volume":"28","author":[{"given":"Valerie","family":"Said-Conti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Persis J.","family":"Amrolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark N.","family":"Gaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Stoneham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Sebire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukshana","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,7]]},"reference":[{"key":"2499_CR1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cncr.24834","volume":"116","author":"R Cavaliere","year":"2010","unstructured":"Cavaliere R, Petroni G, Lopes MB, Schiff D (2010) Primary central nervous system post-transplantation lymphoproliferative disorder. Cancer 116:863\u2013870","journal-title":"Cancer"},{"key":"2499_CR2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/N82CTQ1J0XEVEFQB","volume":"121","author":"AA Castellano-Sanchez","year":"2004","unstructured":"Castellano-Sanchez AA, Li S, Qian J, Lagoo A, Weir E, Brat DJ (2004) Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121:246\u2013253","journal-title":"Am J Clin Pathol"},{"key":"2499_CR3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","volume":"71","author":"DE Tsai","year":"2001","unstructured":"Tsai DE, Hardy CL, Tomaszewski JE, Kotloff RM, Oltoff KM, Somer BG, Schuster SJ, Porter DL, Montone KT, Stadtmauer EA (2001) Reduction in immunosuppression as initial therapy for post transplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 71:1076\u20131088","journal-title":"Transplantation"},{"key":"2499_CR4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1309\/PH2BK79HAVTTPW13","volume":"123","author":"CC Yin","year":"2005","unstructured":"Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA (2005) EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. Am J Clin Pathol 123:222\u2013228","journal-title":"Am J Clin Pathol"},{"key":"2499_CR5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s004670050692","volume":"13","author":"T Srivastava","year":"1999","unstructured":"Srivastava T, Zwick DL, Rothberg PG, Warady BA (1999) Posttransplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol 13:748\u2013754","journal-title":"Pediatr Nephrol"},{"key":"2499_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1399-3046.2006.00497.x","volume":"10","author":"AZ Traum","year":"2006","unstructured":"Traum AZ, Rodig NM, Pilichowska ME, Somers MJG (2006) Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients. Pediatr Transplant 10:505\u2013512","journal-title":"Pediatr Transplant"},{"key":"2499_CR7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.TP.0000079253.06061.52","volume":"76","author":"R Snanoudj","year":"2003","unstructured":"Snanoudj R, Durrbach A, Leblond V, Caillard S, Hurault De Ligny B, Noel C, Rondeau E, Moulin B, Mamzer-Bruneel MF, Lacroix C (2003) Primary brain lymphomas after kidney transplantation: Presentation and outcome. Transplantation 76:930\u2013937","journal-title":"Transplantation"},{"key":"2499_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02698031","volume":"24","author":"NV Frey","year":"2007","unstructured":"Frey NV, Tsai DE (2007) The management of posttransplant lymphoproliferative disorder. Med Oncol 24:125\u2013136","journal-title":"Med Oncol"},{"key":"2499_CR9","first-page":"574","volume":"11","author":"R Purighalla","year":"1997","unstructured":"Purighalla R, Shapiro R, Jordan ML, Scantlebury VP, Gritsch HA, Vivas C, Randhawa PS (1997) Acute renal allograft rejection in patients with Epstein\u2013Barr virus associated post-transplant lymphoproliferative disorder. Clin Transplant 11:574\u2013576","journal-title":"Clin Transplant"},{"key":"2499_CR10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1432-2277.2006.00284.x","volume":"19","author":"J Svoboda","year":"2006","unstructured":"Svoboda J, Kotloff R, Tsai DE (2006) Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab. Transpl Int 19:259\u2013269","journal-title":"Transpl Int"},{"key":"2499_CR11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(05)60684-8","volume":"352","author":"L Rees","year":"1998","unstructured":"Rees L, Thomas A, Amlot PL (1998) Disappearance of an Epstein\u2013Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression. Lancet 352:789","journal-title":"Lancet"},{"key":"2499_CR12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1034\/j.1399-3062.2001.003002104.x","volume":"3","author":"A Durandy","year":"2001","unstructured":"Durandy A (2001) Anti-B cell and anti-cytokine therapy for the treatment of post-transplant lymphoproliferative disorder: past, present, and future. Transplant Infect Dis 3:104\u2013107","journal-title":"Transplant Infect Dis"},{"key":"2499_CR13","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2005.01098.x","volume":"5","author":"SH Oertel","year":"2005","unstructured":"Oertel SH, Verschuuren E, Reinke P, Zeidler K, Papp-V\u00e1ry M, Babel N, Trappe RU, Jonas S, Hummel M, Anagnostopoulos I, D\u00f6rken B, Riess HB (2005) Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 5:2901\u20132906","journal-title":"Am J Transplant"},{"key":"2499_CR14","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","volume":"107","author":"S Choquet","year":"2006","unstructured":"Choquet S, Leblond V, Herbrecht R, Soci\u00e9 G, Stoppa AM, Vandenberghe P, Fischer A, Morschhauser F, Salles G, Feremans W, Vilmer E, Peraldi MN, Lang P, Lebranchu Y, Oksenhendler E, Garnier JL, Lamy T, Jaccard A, Ferrant A, Offner F, Hermine O, Moreau A, Fafi-Kremer S, Morand P, Chatenoud L, Berriot-Varoqueaux N, Bergougnoux L, Milpied N (2006) Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 107:3053\u20133057","journal-title":"Blood"},{"key":"2499_CR15","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2007.12.5062","volume":"25","author":"GD Shah","year":"2007","unstructured":"Shah GD, Yahalom J, Correa DD, Lai RK, Raizer JJ, Schiff D, LaRocca R, Grant B, DeAngelis LM, Abrey LE (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730\u20134735","journal-title":"J Clin Oncol"},{"key":"2499_CR16","doi-asserted-by":"crossref","unstructured":"Choquet S, Oertel S, LeBlond V, Riess H, Varoqueaux N, Dorken B, Trappe R (2007) Rituximab in the management of post-transplantation lymphoproliferative disorder after solid-organ transplantation: proceed with caution. Ann Hematol 86(8):599\u2013609","DOI":"10.1007\/s00277-007-0298-2"},{"key":"2499_CR17","doi-asserted-by":"crossref","unstructured":"Twombley K, Pokala H, Ardura MI, Harker-Murray P, Johnson-Welch SF, Weinberg A, Seikaly M (2012) Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation. Pediatr Transplant 16(6):E201\u20139","DOI":"10.1111\/j.1399-3046.2012.01699.x"},{"key":"2499_CR18","doi-asserted-by":"crossref","unstructured":"Czyzewski K, Styczynski J, Krenska A, Debski R, Zajac-Spychala O, Wachowiak J, Wysocki M (2013) Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder. Leuk Lymphoma (3):503\u20136","DOI":"10.3109\/10428194.2012.718342"},{"key":"2499_CR19","doi-asserted-by":"crossref","unstructured":"Pakakasama S, Eames GM, Morriss MC, Huls MH, Rooney CM, Heslop HE, Krance RA (2004) Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic Tcell lymphocytes. Transplantation 15;78(5):755\u20137","DOI":"10.1097\/01.TP.0000129813.54517.25"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2499-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-013-2499-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2499-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T20:12:43Z","timestamp":1563135163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-013-2499-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,7]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2499"],"URL":"https:\/\/doi.org\/10.1007\/s00467-013-2499-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,7]]}}}